Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-321855
Filing Date
2018-11-08
Accepted
2018-11-08 07:25:07
Documents
71
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d629511d10q.htm 10-Q 747095
2 EX-2.1 d629511dex21.htm EX-2.1 293747
3 EX-4.1 d629511dex41.htm EX-4.1 50484
4 EX-10.1 d629511dex101.htm EX-10.1 230126
5 EX-10.2 d629511dex102.htm EX-10.2 122948
6 EX-31.1 d629511dex311.htm EX-31.1 6362
7 EX-31.2 d629511dex312.htm EX-31.2 6350
8 EX-32.1 d629511dex321.htm EX-32.1 3951
9 EX-32.2 d629511dex322.htm EX-32.2 3938
16 GRAPHIC g629511g76b52.gif GRAPHIC 3190
  Complete submission text file 0001193125-18-321855.txt   4524747

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT srra-20180930.xml EX-101.INS 629457
11 XBRL TAXONOMY EXTENSION SCHEMA srra-20180930.xsd EX-101.SCH 45699
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srra-20180930_cal.xml EX-101.CAL 55297
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srra-20180930_def.xml EX-101.DEF 152038
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE srra-20180930_lab.xml EX-101.LAB 392153
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srra-20180930_pre.xml EX-101.PRE 264643
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Filer) CIK: 0001290149 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37490 | Film No.: 181168169
SIC: 2834 Pharmaceutical Preparations